首页> 外文期刊>Molecular Neurobiology >Carnosic Acid Attenuates 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells by Inducing Autophagy Through an Enhanced Interaction of Parkin and Beclin1
【24h】

Carnosic Acid Attenuates 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells by Inducing Autophagy Through an Enhanced Interaction of Parkin and Beclin1

机译:通过通过Parkin和Beclin1的增强的相互作用诱导自噬诱导自噬核酸在SH-SY5Y细胞中衰减6-羟基多戊胺诱导的神经毒性

获取原文
获取原文并翻译 | 示例
           

摘要

Enhanced removal of abnormal protein aggregates or injured organelles through autophagy is related to neuroprotection in Parkinson's disease. In this study, we explored whether the induction of autophagy is associated with the neuroprotection of rosemary carnosic acid (CA) against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in SH-SY5Y cells. The results indicated that cells treated with CA had increased protein levels of parkin and autophagy-related markers, including phosphatidylinositol 3-kinase p100, Beclin1, autophagy-related gene 7, and microtubule-associated protein 1 light chain 3-II, as well as enhanced formation of autophagic vacuoles. Treatment of cells with 6-OHDA decreased the levels of parkin and the autophagy markers, but CA pretreatment reversed these effects. However, wortmannin (an autophagosome formation blocker) pretreatment attenuated the effect of CA. After CA pretreatment, the induction of cleaved caspase 3, cleaved poly-ADP ribose polymerase, and nuclear condensation by 6-OHDA were alleviated. Both wortmannin and bafilomycin A1 (an autophagosome-lysosome fusion blocker) inhibited the anti-apoptosis effects of CA. Additionally, we performed immunoprecipitation with anti-parkin antibody and found that the interaction of parkin and Beclin1 protein was reduced by 6-OHDA but that this effect was reversed in cells pretreated with CA. Moreover, transfection of parkin siRNA in cells inhibited the ability of CA to alleviate 6-OHDA-decreased autophagy-related markers and nuclear condensation. In conclusion, CA protects against 6-OHDA-induced apoptosis by inducing autophagy through the interaction of parkin and Beclin1. These results provide a future strategy for use of CA in the prevention of Parkinson's disease.
机译:通过自噬增强去除异常蛋白质聚集体或受伤的细胞器与帕金森病的神经保护有关。在这项研究中,我们探讨了自噬诱导是否与迷迭香碳酸(CA)对6-羟基多胺(6-OHDA)诱导的神经毒性的神经保护有关。结果表明,用Ca处理的细胞增加了Parkin和自噬相关标记的蛋白质水平,包括磷脂酰肌醇3-激酶P100,BECLIN1,相关的基因7和微管相关蛋白1轻链3-II以及增强的自噬液压形成。用6-OHDA治疗细胞降低了Parkin和自噬标志物的水平,但Ca预处理扭转了这些效果。然而,Wortmannin(一种自噬体形成阻滞剂)预处理减弱了CA的效果。缓解裂解胱天蛋白酶3的诱导,切割聚 - AdP核糖聚合酶和6-OHDA的诱导被缓解。 Wortmannin和BafiLomycin A1(自噬体溶酶体融合障碍物)均抑制了CA的抗凋亡作用。此外,我们用抗Parkin抗体进行免疫沉淀,发现Parkin和Beclin1蛋白的相互作用减少了6-OHDA,但在用CA预处理的细胞中逆转该效果。此外,细胞中Parkin siRNA的转染抑制Ca缓解6-OHDA减少的自噬相关标记和核凝结的能力。总之,通过通过Parkin和Beclin1的相互作用诱导自噬,CA免受6-OHDA诱导的细胞凋亡。这些结果提供了在预防帕金森病中使用CA的未来策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号